The Mirror US on MSN
Players Championship star makes heartbreaking health admission after brain tumor ordeal
Longtime PGA star Gary Woodland opened up about his PTSD diagnosis in an emotional interview ahead of the Players Championship while admitting he doesn't want to "live a lie' anymore ...
HOUSTON — A Houston family whose story touched hearts at the Houston Livestock Show and Rodeo two years ago returned to the rodeo arena this weekend for another unforgettable moment. In 2024, KHOU 11 ...
An emotional Gary Woodland revealed a diagnosis of post-traumatic stress disorder Monday ahead of THE PLAYERS Championship, ...
When someone has a brain tumor, there are not always symptoms. Sometimes they develop slowly and silently. Chris Podkowiak, 64, of Farmington, loved playing his accordion, traveling with his wife, ...
Malignant gliomas are among the deadliest brain cancers, with limited treatment options and poor survival. A new comprehensive review analyzes decades of global clinical data on boron neutron capture ...
Mackenzie Harry, 25, crossed her first 5K finish line at the River City Half Marathon and 5K on Saturday, March 9. Running was something she and her doctors weren’t sure she’d be able ...
For one woman, the road to answers ran through five different doctors before anyone thought to look inside her skull. Her ...
ASHWAUBENON--The St. Norbert men's hockey team will be hosting a first round NCAA tournament game on Saturday, March 14th at the Cornerstone Community Center.T ...
Chinese Neurosurgical Journal highlights gut–brain axis in pituitary tumor–related cognitive decline
A new study from Kunming Medical University suggests that hormonal imbalance and gut microbiota alterations may contribute to cognitive decline in patients with pituitary neuroendocrine tumors.
Cancer immunotherapies often rely on activating immune responses, yet many tumors remain resistant because their internal survival mechanisms are poorly understood.
Schumaker met Cade Spinello, a survivor of a brain tumor, more than a decade ago through his involvement with the Jessie Rees Foundation.
March 6 (Reuters) - French drugmaker Servier said on Friday it would buy U.S.-based Day One Biopharmaceuticals for about $2.5 billion, expanding its brain tumor treatment portfolio. Servier has ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results